Fair Value Calculator Fair Value Calculator
EN DE

Braskem S.A (BAK) Fair Value & Analysis

Basic Materials · US · Market cap $1.3B

BS Braskem S.A logo Braskem S.A BAK · US
Price$2.71
Fair Value$2.82
Upside+4.2%
Quality31/100
Watch Braskem S.A for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range $1.86 – $3.53

Fair value as of: Jul 14, 2026

From 2 valuation models · updated today

Fair value updated Jul 14, 2026 — revised from $25.71 to $2.82 (−89.0%) since Jun 24, 2026. Share price −26.2% over the past month.

Price vs Fair Value (12 months)

$5.02 $2.35 Fair Value $2.82 Jul 2025 Jul 2026

12‑month range $2.35 – $5.02 · fair‑value band $1.86 – $3.53 · the $2.71 price screens below the $2.82 fair value. As of Jul 14, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Braskem S.A (BAK) currently trades at $2.71, while our model-based Fair Value estimate is $2.82 — implying the stock looks roughly 4.2% fairly valued today. We read business quality at 31/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, Braskem S.A generated revenue of $66.7B at a net margin of -13.7%. Revenue declined 20.4% year over year. Net debt stands at $60.8B. Fundamentals as of Jul 14, 2026

Our scenario range runs from $1.86 (bear case) to $3.53 (bull case); at $2.71, the current price sits within that range. The share trades about 50% below its 52-week high and 17% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -48% fair-value upside — at 4%, BAK screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $66.7B
Revenue growth (YoY) -20.4%
Net margin -13.7%
Return on equity -549%
Free cash flow −$7.2B FY2025
Operating margin -1.0%
More key figures
EPS (TTM) $-4.52
EPS growth (YoY) +107%
Net debt $60.8B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 14, 2026. TTM = trailing twelve months.

About the company

Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. It produces and sells polyethylene (PE), polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, propylene, polyvinyl chloride, caustic soda, butadiene, cumene, naphtha, solvents, and condensate; thermoplastic resins; and basic petrochemicals. The company also supplies electricity and other inputs to second-generation producers; and sale of utilities such as steam, water, compressed air and industrial gases, as well as provides industrial services and natural gas. It also operates in the United States, Mexico, Switzerland, Argentina, Germany, Japan, the Netherlands, Singapore, Chile, Spain, Peru, Italy, Luxembourg, China, and internationally. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Braskem S.A reported revenue of $69.3B in FY2025 versus $106B in FY2021, a compound −10.0%/yr. Reported net income was −$9.7B in FY2025.

Revenue −10.0%/yr
FY21 $106B
FY22 $96.5B
FY23 $70.6B
FY24 $77.4B
FY25 $69.3B
Net income
FY21 $14.0B
FY22 −$336M
FY23 −$4.6B
FY24 −$11.3B
FY25 −$9.7B

Is BAK fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Braskem S.A Fair Value". https://www.fairvalue-calculator.com/stock/BAK

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN €448.00 €191.66 -57%
Shin-Etsu Chemical Co SHECY $22.43 $14.26 -36%
BASF SE BASF 17,146 HUF 8,950 HUF -48%
Dow Inc D1OW34 R$41.12 R$16.66 -59%
Ningxia Baofeng Energy Group 600989 ¥21.72 ¥42.42 +95%
Ganfeng Lithium Group 002460 ¥65.65 ¥18.75 -71%
LG Chem, Ltd 051910 323,000 KRW 311,741 KRW -3%
Hengli Petrochemical Co 600346 ¥16.38 ¥15.62 -5%
Zhejiang Juhua Co 600160 ¥40.39 ¥19.73 -51%
Rongsheng Petrochemical Co 002493 ¥11.43 ¥2.90 -75%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Braskem S.A (BAK) undervalued?
As of Jul 14, 2026, our model estimates a fair value of $2.82 versus a price of $2.71 — about +4% (fairly valued). Model-based estimate, not financial advice.
What is the fair value of BAK?
Our model-based fair value for Braskem S.A is $2.82 (as of Jul 14, 2026), built from audited fundamentals. The current price is $2.71.
What is the quality score of BAK?
Braskem S.A has a Quality Score of 31/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Braskem S.A (BAK)?
Braskem S.A reported trailing-twelve-month revenue of about $66.7B (latest available figure, as of Jul 14, 2026).
What is the net profit margin of BAK?
The net profit margin of Braskem S.A is about -13.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

14 days Pro free · no card

Unlock the full Braskem S.A analysis — and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.